Essential oil therapy in rheumatic diseases: A systematic review

Complement Ther Clin Pract. 2021 May:43:101391. doi: 10.1016/j.ctcp.2021.101391. Epub 2021 Apr 14.

Abstract

Objectives: This paper aims to review articles that have evaluated the role of essential oil therapy in patients with rheumatic diseases.

Methodology: Systematic review. No study design or language limitation was applied.

Results: We have identified 13 articles, most of them were used in osteoarthritis (n = 4), rheumatoid arthritis (n = 3) and fibromyalgia (n = 3). Two studies included patients with RA and OA (n = 2). The number of people involved in the study varied from 9 to 162, where female sex was observed in 60-100%. The age of the patients ranged from 36 to 78.3 years old and disease duration 1-11.67 years. The lavender essential oil was the most used, and then Ginger oil, Rosemary oil, and Rosmarinus officinalis. Time of oil use varied from 2 to 12 weeks. Importantly, all studies but one (91.6%) have demonstrated the efficacy of aromatherapy.

Conclusion: There are few reports on essential oils in rheumatic disease, mainly osteoarthritis, rheumatoid arthritis, and fibromyalgia. All but one study have showed the efficacy of this complementary therapy.

Keywords: Aromatherapy; Essential oils; Fibromyalgia; Lavanda; Osteoarthritis; Rheumatic diseases.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Aged
  • Aromatherapy*
  • Female
  • Humans
  • Lavandula*
  • Middle Aged
  • Oils, Volatile* / therapeutic use
  • Rheumatic Diseases* / drug therapy
  • Rosmarinus*

Substances

  • Oils, Volatile